Virtual Counseling for COVID-19 Vaccine Hesitancy

N/A

Waitlist Available

Led By Geoffrey Curran, PhD

Research Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from baseline through the end of the virtual facilitation periods, up to 24 weeks maximum.

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if using virtual facilitation, like video coaching, helps rural pharmacists better counsel patients on COVID-19 vaccine hesitancy compared to the standard approach. Participants will start with

Who is the study for?

This trial is for rural pharmacists who are looking to improve their ability to counsel patients with COVID-19 vaccine hesitancy. Participants should be currently practicing in a rural pharmacy and willing to undergo training and coaching sessions.

What is being tested?

The study tests if virtual coaching helps pharmacists better implement COVID-19 vaccine hesitancy counseling compared to just webinar training. Pharmacists start with standard online training, then move on to personalized video coaching, with their performance observed over time.

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience increased workload or stress due to additional training and observation requirements.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline through the end of the virtual facilitation periods, up to 24 weeks maximum.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline through the end of the virtual facilitation periods, up to 24 weeks maximum.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline through the end of the virtual facilitation periods, up to 24 weeks maximum. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Mean Fidelity Score

Secondary study objectives

Proportion of Individuals Receiving Vaccine Hesitancy Counseling Who Chose to Get the COVID-19 Vaccine

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Virtual facilitation (Stage 2)Experimental Treatment1 Intervention

After completing the standard implementation, participants then complete the virtual facilitation intervention for 8-16 weeks, depending on random block assignment.

Group II: Standard implementation (Stage 1)Experimental Treatment1 Intervention

Participants begin with the standard implementation interventions for 8-16 weeks, depending on random block assignment.

Do I qualify?Apply below to find out